Seven minutes. That’s how long you’d have to pitch your cryptocurrency idea to actor Andrew Duplessie, an angel investor in the space.
Then he’d grill you for seven more minutes to make sure you know what you’re talking about and that you’re not just jumping on the bandwagon.
“[There] are a lot of people trying to take advantage of the bubble,” said Duplessie during a sit-down interview with Cheddar.
Duplessie believes the cryptocurrency industry will continue to evolve from being dominated by programmers into a hub for visionaries.
“We’re seeing more legit entrepreneurs that really think about consumers,” he said. “[They] may not be able to code, but they have a really great vision for user interface and design.”
He also says start-ups that have already secured Series A or Series B funding are “considering ICOs” in the future.
“It only adds a greater value to the entire movement,” Duplessie said.
For full interview, [click here](https://cheddar.com/videos/actor-andrew-duplessie-on-investing-in-crypto).
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
